Drug/Small Molecule:
cloxacillin

2D structure

Overview

Generic Names: Cloxacillin Sodium
IUPAC Name: (2S,5R,6R)-6-[[3-(2-chlorophenyl)-5-methyl1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
Trade Names: Novo-Cloxin; Nu-Cloxi
PharmGKB Accession Id: PA449059

Description

A semi-synthetic antibiotic that is a chlorinated derivative of oxacillin. [PubChem]

Indication

Used to treat infections caused by penicillinase-producing staphylococci, including pneumococci, group A beta-hemolytic streptococci, and penicillin G-sensitive and penicillin G-resistant staphylococci.

ATC Therapeutic Category

  • J01CF:Beta-lactamase resistant penicillins

Pharmacology and Interactions

Mechanism Of Action

By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, cloxacillin inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that cloxacillin interferes with an autolysin inhibitor.

Pharmacology

Cloxacillin is a semisynthetic antibiotic in the same class as penicillin. Cloxacillin is for use against staphylococci that produce beta-lactamase.

Food Interactions

Take on an empty stomach.

Absorption, Distribution, Metabolism, Elimination & Toxicity

Protein Binding

95%

Absorption

Well absorbed from the gastrointestinal tract.

Toxicity

Oral LD50 in rat and mouse is 5000 mg/kg. Intravenous LD50 in rat is 1660 mg/kg. Symptoms of overdose include wheezing, tightness in the chest, fever, itching, bad cough, blue skin color, fits, and swelling of face, lips, tongue, or throat.

Chemical Properties

Chemical Formula:

C19H18ClN3O5S

SMILES Code:

Cc1c(c(no1)c2ccccc2Cl)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O

(Format: OpenEye Isomeric)

Molecular Weight ( average / monoisotopic )

435.881 / 435.0656

Non-Curated Information

A list of non-curated publications that mention this drug along with other genes is available.

Drug Targets

Non-Curated Information

A list of non-curated publications that mention this drug along with other drugs is available.

Drug Interactions

acenocoumarol The IV penicillin increases the anticoagulant effect
anisindione The IV penicillin increases the anticoagulant effect
demeclocycline Possible antagonism of action
dicumarol The IV penicillin increases the anticoagulant effect
doxycycline Possible antagonism of action
ethinyl estradiol This anti-infectious agent could decrease the effect of the oral contraceptive
mestranol This anti-infectious agent could decrease the effect of the oral contraceptive
methacycline Possible antagonism of action
methotrexate The penicillin increases the effect and toxicity of methotrexate
minocycline Possible antagonism of action
oxytetracycline Possible antagonism of action
rolitetracycline Possible antagonism of action
tetracycline Possible antagonism of action
warfarin The IV penicillin increases the anticoagulant effect

Non-Curated Information

A list of non-curated publications that mention this drug along with other diseases is available.

Additional Datasets

These datasets are minimally curated and are sorted alphabetically by title.

  1. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease

LinkOuts

Web Resource:
Wikipedia
DrugBank:
DB01147
ChEBI ID:
3765
KEGG Compound ID:
C06923
PubChem Compound ID:
6098
PubChem Substance ID:
9140

Common Searches

Search PubMed
Search Medline Plus
Search PubChem
Search CTD

Non-Curated Publications

A list of non-curated publications that mention this drug is available.

PharmGKB integrates drug information from different sources: DrugBank, Open Eye Scientific Software.
The PharmGKB is financially supported by the NIH/ NIGMS and is managed at Stanford University (U01GM61374).
©2001-2010 PharmGKB.